Importance of hyperlipidaemia and therapy in renal patients
Open Access
- 2 October 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 15 (suppl_5) , 92-96
- https://doi.org/10.1093/ndt/15.suppl_5.92
Abstract
Christoph Wanner; Importance of hyperlipidaemia and therapy in renal patients, Nephrology Dialysis Transplantation, Volume 15, Issue suppl_5, 2 October 2000, PThis publication has 30 references indexed in Scilit:
- Urinary Albumin ExcretionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Effects of erythropoietin therapy on the lipid profile in end-stage renal failureKidney International, 1994
- Serum Lipids Predict Cardiac Death in Diabetic Patients on Maintenance HemodialysisNephron, 1993
- Pattern of Hyperlipoproteinemia in Human Nephrotic Syndrome: Influence of Renal Failure and Diabetes mellitusNephron, 1993
- Dyslipoproteinemia in diabetic renal failureKidney International, 1992
- Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysisKidney International, 1991
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991
- Albumin synthesis, albuminuria and hyperlipemia in nephrotic patientsKidney International, 1987
- The Hyperlipidemia of the Nephrotic SyndromeNew England Journal of Medicine, 1985